Bicocca Open Archive

Logo unimib boa
SQUILLACE, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.087
EU - Europa 1.490
AS - Asia 417
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
AF - Africa 2
Totale 5.013
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.034
IT - Italia 367
DE - Germania 333
SE - Svezia 264
IE - Irlanda 249
CN - Cina 181
HK - Hong Kong 109
GB - Regno Unito 71
VN - Vietnam 64
UA - Ucraina 57
CA - Canada 52
DK - Danimarca 41
IN - India 31
FI - Finlandia 30
BE - Belgio 14
NL - Olanda 13
RU - Federazione Russa 11
FR - Francia 10
PL - Polonia 7
TR - Turchia 7
SG - Singapore 6
AT - Austria 5
CH - Svizzera 4
CO - Colombia 4
IR - Iran 4
JP - Giappone 4
EU - Europa 3
PH - Filippine 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
CZ - Repubblica Ceca 2
ES - Italia 2
LU - Lussemburgo 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PE - Perù 2
TH - Thailandia 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
KR - Corea 1
LT - Lituania 1
NG - Nigeria 1
PT - Portogallo 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 5.013
Salva come PNG Salva come JPEG
Città #
Ann Arbor 926
Fairfield 281
Frankfurt am Main 281
Dublin 243
Chandler 240
New York 226
Wilmington 193
Ashburn 146
Woodbridge 142
Houston 132
Hong Kong 109
Seattle 102
Princeton 91
Cambridge 75
Milan 68
Dearborn 56
Jacksonville 50
Dong Ket 41
Lawrence 41
Altamura 38
Shanghai 36
Nanjing 27
San Diego 24
Guangzhou 23
London 22
Ottawa 20
Fremont 18
Beijing 17
Helsinki 17
Rome 15
Andover 14
Brussels 13
Falls Church 13
Monza 10
Pune 10
Toronto 10
Lachine 9
Nanchang 9
Edmonton 8
Shenyang 8
Turin 8
Boardman 7
Carate Brianza 7
Jinan 7
Palermo 7
Casorate Primo 6
Hangzhou 6
Naples 6
Acquafredda 5
Bresso 5
Gallarate 5
Kiev 5
Washington 5
Bogotá 4
Casier 4
Changsha 4
Edinburgh 4
Hanoi 4
Hebei 4
Kunming 4
Lissone 4
Polska 4
Tianjin 4
Amsterdam 3
Frattamaggiore 3
Genova 3
Glasgow 3
Kilburn 3
Lappeenranta 3
Leawood 3
Los Angeles 3
Maastricht 3
Mariano Comense 3
Muggiò 3
Norwalk 3
Pioltello 3
San Francisco 3
Santa Clara 3
Shenzhen 3
Tokyo 3
Vienna 3
Zurich 3
Atlanta 2
Auckland 2
Bangalore 2
Bangkok 2
Bari 2
Bhubaneswar 2
Catania 2
Chennai 2
Chiswick 2
Clearwater 2
Deiva Marina 2
Delhi 2
Florence 2
Genoa 2
Gunzenhausen 2
Hyderabad 2
Ivrea 2
Lanzhou 2
Totale 4.016
Salva come PNG Salva come JPEG
Nome #
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 223
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 210
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 202
Switch da Tenofovir disoproxil fumarato (TDF) a Tenofovir alafenamide (TAF) e aumento del colesterolo: impatto sulla valutazione del rischio cardiovascolare 174
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 173
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 173
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 170
Brachial and central blood pressure in HIV-infected subjects 167
Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated with the Evolution of Cognitive Performance in HIV-Infected Patients 166
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 155
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 154
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 153
Unmasking tuberculosis in the era of antiretroviral treatment 151
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 151
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 150
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances 147
Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment? 134
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 122
The role for tocilizumab in covid-19 patients: Reflections on monza cohort data 115
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 107
Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible from the STOPSHIV Project Cohort 102
Weight gain: A possible side effect of all antiretrovirals 95
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study 90
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 87
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 82
Arterial structure and function in AIDS patients: the impact of renal damage. 81
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 81
Factors associated with hospital admission for COVID-19 in HIV patients 79
Factors Associated With Weight Gain in People Treated With Dolutegravir 78
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 76
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 76
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 74
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 73
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 71
A multidisciplinary approach to screen the post-COVID-19 conditions 69
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project 68
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 63
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 63
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 59
Early changes in adhesion molecules expression and endothelial function in patients initiating ART with Atazanavir or Lopinavir 56
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 55
Arterial structural and functional effects of two different antiretroviral therapy protocol on naïve HIV-infected subjects 54
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 52
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 49
Frailty and long-COVID: is COVID-19 responsible for a transition in frailty status among older adults who survived hospitalization for COVID-19? 49
Invecchiare con la terapia antiretrovirale o essere anziani in terapia antiretrovirale: due profili di comorbidità differenti? 48
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile 46
Fattori associati con il ricovero ospedaliero per COVID-19 in 80 pazienti HIV-positivi italiani. Factors associated with hospital admission for COVID-19 in 80 Italian HIV patients. 41
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 33
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 31
Reversibility of Central Nervous System Adverse Events in Course of Art 30
HIV and SARS-CoV-2 Co-Infection: What are the Risks? 27
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study 24
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study 24
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? 23
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens 19
Incident diabetes in course of antiretroviral therapy 19
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda 14
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 9
Totale 5.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.311
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019133 0 0 0 0 0 0 0 0 0 27 41 65
2019/2020683 53 39 40 23 27 63 60 58 76 72 84 88
2020/20211.293 54 78 101 117 99 175 126 139 94 117 61 132
2021/2022692 75 63 82 61 19 48 18 34 18 60 68 146
2022/20231.272 135 346 108 104 67 193 23 103 84 21 50 38
2023/2024906 51 18 69 29 119 315 165 48 83 9 0 0
Totale 5.367